A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells-Reference-Cited by-同舟云学术

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

Published:2006-03-12 Issue:4 Volume:12 Page:410-416
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Lee Ju-Seog,Heo Jeonghoon,Libbrecht Louis,Chu In-Sun,Kaposi-Novak Pal,Calvisi Diego F,Mikaelyan Arsen,Roberts Lewis R,Demetris Anthony J,Sun Zongtang,Nevens Frederik,Roskams Tania,Thorgeirsson Snorri S

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1377.pdf

Reference40 articles.

1. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94, 153–156 (2001).

2. El Serag, H.B. & Mason, A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745–750 (1999).

3. Bruix, J., Boix, L., Sala, M. & Llovet, J.M. Focus on hepatocellular carcinoma. Cancer Cell 5, 215–219 (2004).

4. Llovet, J.M. et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29, 62–67 (1999).

5. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57–70 (2000).

Cited by 839 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomas;2024-09-03

2. Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females;2024-07-18

3. Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females;2024-07-18

4. Cell polyploidy. Cardiac muscle. Liver. Ontogenesis and regeneration;Журнал общей биологии;2024-07-11

5. SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023);Clinical and Translational Oncology;2024-06-24